Zenas BioPharma, Inc. (ZBIO) Reports a Net Loss for Q4 FY25
$ZBIO Zenas BioPharma, Inc. (ZBIO) reported Q4 2025 GAAP loss of $4.54 per share, missing analysts’ estimates. The company did ...
Tuesday, September 15, 2026
Tag: ZBIO
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.